Produkty 116122-36-2

CAS 116122-36-2 występuje w naszej ofercie pod nazwami: BREVISCAPIN, Breviscapine, 95.59%, Breviscapine, 80%. Oferty producentów: GLPBio, MedChemExpress, Chemat. Dostępne opakowania: 5g, 100 mg, 25 mg, 50 mg, 1g, 25g, 100g.

BREVISCAPIN
GLPBio
  • opakowanie: 5g
  • Warianty: 1
od 554,92
Zobacz produkt
Breviscapine, 95.59%
MedChemExpress
  • opakowanie: 100 mg, 25 mg, 50 mg
  • Warianty: 3
od 263,96
Zobacz produkt
Breviscapine, 80%
Chemat
  • opakowanie: 1g, 5g, 25g, 100g
  • Warianty: 4
od 102,80
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid (CAS 116122-36-2) to związek chemiczny o wzorze sumarycznym C21H18O12 i masie molowej 462.4 g/mol. Nazwa systematyczna IUPAC: 6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid. InChIKey: DJSISFGPUUYILV-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H18O12
Masa molowa462.4 g/mol
Nazwa IUPAC6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid
InChIKeyDJSISFGPUUYILV-UHFFFAOYSA-N
SMILESC1=CC(=CC=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)C(=O)O)O)O)O)O)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: Breviscapine, scutellarin [M+H]+, s3810
Powiązane formy tego związku
(2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid C21H18O12
Izomery (ten sam wzór sumaryczny)
(2S,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid C21H18O12
(2S,3S,4S,5R,6S)-6-[2-(3,4-dihydroxyphenyl)-5-hydroxy-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid C21H18O12
(2S,3S,4S,5R,6S)-6-[3,5-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid C21H18O12
(2S,3S,4S,5R,6S)-6-[5-(5,7-dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C21H18O12
6,7-dihydroxy-14-methoxy-13-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione C21H18O12
6,14-dihydroxy-7-methoxy-13-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione C21H18O12
6-hydroxy-7,14-dimethoxy-13-(3,4,5-trihydroxyoxan-2-yl)oxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione C21H18O12
(2S,3S,4S,5R,6S)-6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-8-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid C21H18O12
(2S,3S,4S,5R,6S)-6-[4-(5,7-dihydroxy-4-oxochromen-2-yl)-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid C21H18O12